middle.news
Immutep finds a possible manufacturing clue and resets efti development
8:04am on Thursday 29th of October, 2026 AEDT
•
Biotechnology
Read Story
Immutep finds a possible manufacturing clue and resets efti development
8:04am on Thursday 29th of October, 2026 AEDT
Key Points
Structural differences identified between 2,000 L and 200 L efti batches
New 200 L manufacturing run contracted, with trial starts targeted for H2 CY27
Future efti focus narrowed to CPS <1 HNSCC and neoadjuvant soft tissue sarcoma
IMP761 elevated to co-priority ahead of November ACR data
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Immutep (ASX:IMM)
OPEN ARTICLE